Literature DB >> 10193509

Genetic risk factors in Alzheimer's disease.

L Tilley1, K Morgan, N Kalsheker.   

Abstract

Following a brief introduction and discussion of the pathological features of Alzheimer's disease, the main emphasis of this review article will be the genetic factors that have been implicated in this disease. These can be divided into two main categories. First, the three genes in which mutations are known to result in early onset autosomal dominant familial Alzheimer's disease will be discussed. These are well characterised but account for only a small proportion of Alzheimer's disease cases. Late onset, sporadic Alzheimer's disease is more common and evidence suggests that there is a genetic component to this type of disease. A number of genetic risk factors have been implicated that might increase the risk of developing sporadic disease. Many of these are controversial and studies have shown conflicting results, which are discussed in this section. Finally, a brief discussion of some of the mechanisms suggested to play a role in the pathogenesis of Alzheimer's disease is included. It is hoped that this will show why particular genes have been implicated in Alzheimer's disease and how they might be able to influence the development of the disease.

Entities:  

Mesh:

Year:  1998        PMID: 10193509      PMCID: PMC395655          DOI: 10.1136/mp.51.6.293

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  173 in total

1.  A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene.

Authors:  J Perez-Tur; S Froelich; G Prihar; R Crook; M Baker; K Duff; M Wragg; F Busfield; C Lendon; R F Clark
Journal:  Neuroreport       Date:  1995-12-29       Impact factor: 1.837

2.  Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance.

Authors:  S D Edland; J M Silverman; E R Peskind; D Tsuang; E Wijsman; J C Morris
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

3.  Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease.

Authors:  H Braak; E Braak; J Bohl; R Reintjes
Journal:  Neurosci Lett       Date:  1996-05-31       Impact factor: 3.046

4.  Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.

Authors:  K Duff; C Eckman; C Zehr; X Yu; C M Prada; J Perez-tur; M Hutton; L Buee; Y Harigaya; D Yager; D Morgan; M N Gordon; L Holcomb; L Refolo; B Zenk; J Hardy; S Younkin
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

5.  Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease.

Authors:  K Okuizumi; O Onodera; K Seki; H Tanaka; Y Namba; K Ikeda; A M Saunders; M A Pericak-Vance; A D Roses; S Tsuji
Journal:  Ann Neurol       Date:  1996-08       Impact factor: 10.422

6.  No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians.

Authors:  M L Pritchard; A M Saunders; P C Gaskell; G W Small; P M Conneally; B Rosi; L H Yamaoka; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Neurosci Lett       Date:  1996-05-10       Impact factor: 3.046

7.  Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

Authors:  D Scheuner; C Eckman; M Jensen; X Song; M Citron; N Suzuki; T D Bird; J Hardy; M Hutton; W Kukull; E Larson; E Levy-Lahad; M Viitanen; E Peskind; P Poorkaj; G Schellenberg; R Tanzi; W Wasco; L Lannfelt; D Selkoe; S Younkin
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

Review 8.  The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.

Authors:  R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  1996-10       Impact factor: 3.685

9.  Polymorphism in AACT gene may lower age of onset of Alzheimer's disease.

Authors:  C Talbot; H Houlden; N Craddock; R Crook; M Hutton; C Lendon; G Prihar; J C Morris; J Hardy; A Goate
Journal:  Neuroreport       Date:  1996-01-31       Impact factor: 1.837

10.  Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease.

Authors:  B Nacmias; A Tedde; S Latorraca; S Piacentini; L Bracco; L Amaducci; B M Guarnieri; C Petruzzi; L Ortenzi; S Sorbi
Journal:  Ann Neurol       Date:  1996-10       Impact factor: 10.422

View more
  14 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  "Forward genetics" as a method to maximize power and cost-efficiency in studies of human complex traits.

Authors:  M P M Boks; E M Derks; C V Dolan; R S Kahn; R A Ophoff
Journal:  Behav Genet       Date:  2010-03-16       Impact factor: 2.805

Review 3.  Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease.

Authors:  J T Huse; R W Doms
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

4.  Postgenomics, uncertain futures, and the familiarization of susceptibility genes.

Authors:  Gillian Chilibeck; Margaret Lock; Megha Sehdev
Journal:  Soc Sci Med       Date:  2010-05-08       Impact factor: 4.634

Review 5.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

6.  Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.

Authors:  Lee J Martin
Journal:  Pharmaceuticals (Basel)       Date:  2010

Review 7.  Biology of mitochondria in neurodegenerative diseases.

Authors:  Lee J Martin
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

8.  Limited clearance of pre-existing amyloid plaques after intracerebral injection of Abeta antibodies in two mouse models of Alzheimer disease.

Authors:  Stina M Fangmark Tucker; David R Borchelt; Juan C Troncoso
Journal:  J Neuropathol Exp Neurol       Date:  2008-01       Impact factor: 3.685

Review 9.  mtDNA Mutations and Their Role in Aging, Diseases and Forensic Sciences.

Authors:  Sara C Zapico; Douglas H Ubelaker
Journal:  Aging Dis       Date:  2013-10-03       Impact factor: 6.745

10.  Normal tension glaucoma is not associated with the common apolipoprotein E gene polymorphisms.

Authors:  S Lake; E Liverani; M Desai; R Casson; B James; A Clark; J F Salmon
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.